Autres langues UCB

Actions

UCB

BE0003739530

Produits pharmaceutiques

Temps réel Euronext Bruxelles 17:35:00 04/09/2026			Varia. 5j.	Varia. 1 janv.
210,60 ^EUR	-4,58%		-2,73%	-11,74%

01/09	Les laboratoires pharmaceutiques mondiaux ayant officiellement annoncé des accords de prix avec Trump	RE
01/09	La Maison Blanche conclut un accord avec neuf laboratoires pour réduire le prix des médicaments	MT

Autres langues

03/09	Advancing the future of rare disease diagnosis: Aspire4Rare's next chapter
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
01/09	White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies
01/09	Degroof Petercam verlaagt koersdoel UCB
01/09	UCB bereikt akkoord met Amerikaanse overheid
31/08	Trump announces new round of drug-pricing deals
31/08	Ucb Sa Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
31/08	Trump Announces Nine New Drug Pricing Deals With Pharmaceutical Companies
31/08	Trump Administration Reaches Most-Favored-Nation Drug Pricing Deals With 9 Companies
31/08	UCB bereikt akkoord met Amerikaanse overheid
31/08	UCB : Transparency notification Wellington Management Group LLP
29/08	Indexzwaargewichten helpen Bel20 aan nieuw record
20/08	Cancer vaccines finally garner the spotlight
19/08	Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands
18/08	UCB : An unimpressive upgrade-led correction opens a rare opportunity
16/08	Lotus Bakeries bereikt hoogste koers ooit
13/08	KBC Securities verlaagt koersdoel UCB
11/08	Berenberg Adjusts UCB Forecasts After H1 Beat; Buy Reaffirmed
11/08	Berenberg herhaalt koopadvies UCB
10/08	MoonLake's psoriatic arthritis drug meets key goals in late-stage trial
05/08	UCB Publishes Results Of Post Hoc Data Analysis Of Fintepla In Patients With Lennox-Gastaut Syndrome
03/08	Barclays verlaagt koersdoel UCB
03/08	Jefferies haalt UCB van de verkooplijst
02/08	Umicore en Syensqo blinken uit na cijfers
30/07	UCB SA Reports Earnings Results for the Half Year Ended June 30, 2026